Physiologically based pharmacokinetic modelling: a sound mechanistic basis is needed.
about
Microfabricated mammalian organ systems and their integration into models of whole animals and humansModeling antiretroviral drug responses for HIV-1 infected patients using differential equation modelsCombining the 'bottom up' and 'top down' approaches in pharmacokinetic modelling: fitting PBPK models to observed clinical dataAn imaging-driven model for liposomal stability and circulation.Translational pharmacokinetics: challenges of an emerging approach to drug development in stroke.Using physiologically-based pharmacokinetic-guided "body-on-a-chip" systems to predict mammalian response to drug and chemical exposureImproved prediction of tacrolimus concentrations early after kidney transplantation using theory-based pharmacokinetic modellingCancer pharmacotherapy: 21st century 'magic bullets' and changing paradigms.Semiphysiologically Based Pharmacokinetic Model of Leflunomide Disposition in Rheumatoid Arthritis Patients.Oseltamivir pharmacokinetics and clinical experience in neonates and infants during an outbreak of H1N1 influenza A virus infection in a neonatal intensive care unitWhole-body physiologically based pharmacokinetic models.Quantitative Systems Pharmacology: A Framework for Context.Physiologically based pharmacokinetics (PBPK).Drug Development for Pediatric Populations: Regulatory Aspects.Integration of in silico and in vitro platforms for pharmacokinetic-pharmacodynamic modeling.Utility of a physiologically-based pharmacokinetic (PBPK) modeling approach to quantitatively predict a complex drug-drug-disease interaction scenario for rivaroxaban during the drug review process: implications for clinical practice.Physiologically based pharmacokinetic (PBPK) modeling in children.Organ-on-a-chip technology and microfluidic whole-body models for pharmacokinetic drug toxicity screening.In silico ADME/T modelling for rational drug design.Array of translational systems pharmacodynamic models of anti-cancer drugs.A physiologically based pharmacokinetic model for strontium exposure in rat.Microtechnology-Based Multi-Organ Models.From pharmacology to immunopharmacology.Today's science, tomorrow's medicines.Prediction of human prenatal exposure to bisphenol A and bisphenol A glucuronide from an ovine semi-physiological toxicokinetic model.Organ-on-a-Chip Technology for Reproducing Multiorgan Physiology.Skin Diseases Modeling using Combined Tissue Engineering and Microfluidic Technologies.
P2860
Q27011459-DB32BEF6-897D-4298-8705-7CE7F8310D56Q27015861-7EADD7BC-BD14-43F4-BFDB-0137921970AFQ30666721-AD114918-4473-49B7-A328-AEC783609FD4Q33839139-E5A0B896-1D38-47E0-BB42-05F790FC32A1Q33882182-1ECE7C3E-4746-40B0-8BB7-733D7FA7DC73Q34143269-4440549A-BB77-4CEC-8ABC-B3C40C208F3DQ34571036-C40ECCCA-0B5A-4CA6-A61E-7278DBEA2A43Q35827640-E354938D-3B6B-4EDE-B293-5317DF09BD2BQ35861714-CAF88C5D-20A2-477C-975D-70323B713C97Q36086446-B70AF0DF-DCE7-4C62-9D62-68425FA520E0Q36788418-C161CDEC-CC6B-4BF6-8462-75B2666CFA59Q37200950-33C011EF-21DF-4A9F-BDC5-BF436D4785A7Q37550553-504AD2DC-903F-4669-A156-FC0C69A03C08Q37666706-58436EC6-0FD9-47C4-B90A-6F3E5835D547Q37764345-4BE31321-B39D-40D7-B4C3-919B2292BC04Q37978192-B7BA2C4B-8FA1-4CA6-9355-E1D10B56C7E8Q38016332-131049D9-C8A5-4B46-A8A7-1BA80086DB3CQ38137976-0402B8C9-EE39-42B3-BC6D-8290B6620D95Q38578341-7778F2C0-3236-46CC-8DF9-B0479D97C446Q38988505-E681E7F6-1F04-457F-89E1-99FFBA805AF1Q39442485-49542263-9E9F-490D-98C4-55C388E59A1AQ41704262-7F60D21D-A40B-4DC1-83B3-86757C4C65A8Q42758214-44285FA0-14D5-4342-B316-4DCBC3A7D568Q46154777-8735B0A6-1004-487B-8C03-66A1118C153EQ47168396-E85624CC-05B4-4881-B282-178983E25B6AQ47637355-539EFB6B-C453-4A57-93F7-2F829EA041F3Q51189813-05CE55D8-E694-4230-B739-E108D42A8002
P2860
Physiologically based pharmacokinetic modelling: a sound mechanistic basis is needed.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Physiologically based pharmacokinetic modelling: a sound mechanistic basis is needed.
@en
Physiologically based pharmacokinetic modelling: a sound mechanistic basis is needed.
@nl
type
label
Physiologically based pharmacokinetic modelling: a sound mechanistic basis is needed.
@en
Physiologically based pharmacokinetic modelling: a sound mechanistic basis is needed.
@nl
prefLabel
Physiologically based pharmacokinetic modelling: a sound mechanistic basis is needed.
@en
Physiologically based pharmacokinetic modelling: a sound mechanistic basis is needed.
@nl
P2860
P1476
Physiologically based pharmacokinetic modelling: a sound mechanistic basis is needed.
@en
P2093
P2860
P304
P356
10.1111/J.1365-2125.2005.02560.X
P407
P577
2005-12-01T00:00:00Z